Technical Comparison
Virax Biolabs Group Limited - Ordinary Shares vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between VRAX and NVDA.
Primary Asset
VRA
Virax Biolabs Group Limited - Ordinary Shares
Market Rank #1005166Live Price$1.19
Market Capitalization$1.6M
24h Change+0.00%
Circulating Supply1.3M VRAX
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$217.94
Market Capitalization$5.3T
24h Change+0.90%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | VRAX Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1005166 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $1.19 | $217.94 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $1.6M | $5.3T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is Virax Biolabs Group Limited - Ordinary Shares bigger than NVIDIA Corporation - Common Stock?
Virax Biolabs Group Limited - Ordinary Shares has a market cap of $1.6M, while NVIDIA Corporation - Common Stock sits at $5.3T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between Virax Biolabs Group Limited - Ordinary Shares and NVIDIA Corporation - Common Stock?
Currently, 1 VRAX is worth 0.005460 NVDA.